-
CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer
Slapak, E. J., el Mandili, M., ten Brink, M. S., Kros, A., Bijlsma, M. F. & Spek, C. A., 28 May 2024, In: Cancer Letters. 590, 216845.Research output: Contribution to journal › Article › Academic › peer-review
-
Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer
Slapak, E. J., el Mandili, M., Brink, M. S. T., Kros, A., Bijlsma, M. F. & Spek, C. A., 1 Jul 2023, In: International journal of molecular sciences. 24, 13, 10704.Research output: Contribution to journal › Article › Academic › peer-review
-
Mesoporous Silica Nanoparticle-Based Drug Delivery Systems for the Treatment of Pancreatic Cancer: A Systematic Literature Overview
Slapak, E. J., el Mandili, M., Bijlsma, M. F. & Spek, C. A., 1 Feb 2022, In: Pharmaceutics. 14, 2, 390.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
